Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations

Published:2024-08 Issue: Volume:207 Page:114158
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kron Anna,Scheffler Matthias,Wiesweg Marcel,Hummel Horst-Dieter,Kulhavy Jonas,Gatteloehner Stefan,Kollmeier Jens,Schubart Christoph,Groß Thorben,Demes Melanie-Christin,Keymel Stefanie,Joosten Maria,Merkelbach-Bruse Sabine,Wölwer Christina Bianca,Tufman Amanda,Kauffmann-Guerrero Diego,Oeser Katharina,Zehaczek Melanie,Jeratsch Ulli,Wolf Juergen

Publisher

Elsevier BV

Reference30 articles.

1. Profiling of oncogenic driver events in lung adenocarcinoma revealed MET mutation as independent prognostic factor;Yeung;J Thorac Oncol,2015

2. MET Exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent met genomic amplification and c-Met overexpression;Awad;J Clin Oncol,2016

3. Characterization of 298 patients with lung cancer harboring MET exon 14 skipping alterations;Schrock;J Thorac Oncol,2016

4. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer - A systematic review and meta-analysis;Vuong;Lung Cancer,2018

5. Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping;Paik;Cancer Discov,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP